Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
siRNAgen Therapeutics logo — Harnessing the SAMiRNA™ platform to revolutionize the treatm...

siRNAgen Therapeutics

Harnessing the SAMiRNA™ platform to revolutionize the treatment of immunology and CNS diseases

Founded 2019 United States Cambridge, United States 6 employees Health Care

General Information

Company Name siRNAgen Therapeutics
Founded Year 2019
Location United States Cambridge, United States +1
Employees 6
Industries Health Care
Social

Get notified when siRNAgen Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About siRNAgen Therapeutics

siRNAgen Therapeutics is a 2019-founded health care startup that aims to revolutionize the treatment of immunology and CNS diseases. Through their proprietary SAMiRNA™ platform, the company leverages modular chemistry to address the delivery challenges associated with RNAi therapy. Their flagship product, SRN-001, shows great promise in treating fibrotic diseases worldwide. With a commitment to innovation and collaboration, siRNAgen continues to push the boundaries of scientific discovery to positively impact the lives of patients globally.

Taxonomy: RNAi platform, biotech, pharmaceutical, immunology, CNS diseases, fibrosis, dermatology, oncology, clinical stage

No funding data available for siRNAgen Therapeutics yet.

Get notified when siRNAgen Therapeutics raises funding

siRNAgen Therapeutics Alternatives & Competitors

siRNAgen Therapeutics vs
LabSD, Inc.
LabSD, Inc. Korea South

EYELIKE™ the world without avoidable blindness.

Non Equity Assistance
11 employees
Health Care, Information Technology
siRNAgen Therapeutics vs
Orbit Genomics
Orbit Genomics United States

The Future of Precision Healthcare

Unknown
8 employees
siRNAgen Therapeutics vs
Savicell
Savicell Israel

THE IMMUNOBIOPSY™ COMPANY – BECAUSE EARLY DETECTION IS LIFE™

7 employees
Biotechnology, Health Care

FAQ About siRNAgen Therapeutics

Harnessing the SAMiRNA™ platform to revolutionize the treatment of immunology and CNS diseases
siRNAgen Therapeutics was founded in 2019.
siRNAgen Therapeutics is headquartered in Cambridge, United States.
siRNAgen Therapeutics operates in the following industries: Health Care.
siRNAgen Therapeutics has approximately 6 employees.
Top alternatives and competitors to siRNAgen Therapeutics include LabSD, Inc., Orbit Genomics, Savicell, Atara Biotherapeutics, betaSENSE. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
siRNAgen Therapeutics and LabSD, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors siRNAgen Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes